Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities - a Randomized Controlled Parallel Assigned Study
Condition: Major Depressive Disorder Interventions: Drug: Vortioxetine; Drug: Venlafaxine Sponsors: Scotmann Pharmaceuticals; Rawalpindi Medical College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2021 Category: Research Source Type: clinical trials
The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
Conditions: Acute Pain; Chronic Pain; Knee Pain Chronic; Neuropathic Pain Interventions: Drug: Venlafaxine 37.5 MG; Drug: Placebo Sponsors: University of California, San Francisco; Orthopedic Research and Education Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2021 Category: Research Source Type: clinical trials